doi: 10.3389/fphar.2025.1617546 Received 24 April 2025 Accepted 21 July 2025 Published 31 July 2025 Volume 16 - 2025 Edited by Izolde Bouloukaki, University of Crete, Greece Reviewed by Maimaiti Tuniyazi, Jilin University, China zhiqiang Dou, Changchun University of Chinese Medicine, China Xue Wan, Mayo Clinic, United States Updates Copyright 2025 Lv, Zhang, Liu, Wang and Zhao
In subjects with baseline glucose disposal rates below 7.9 mg/kg per minute, acetyl-L-carnitine treatment significantly increased insulin sensitivity and improved glucose tolerance, with some individuals transitioning from impaired glucose tolerance to normal glucose metabolism
Unfortunately, the space has also attracted a wave of underdosed, mislabeled, and outright fraudulent suppliers who sell impure compounds with no documentation
Betul Ibis and colleagues, used the TriNetX database to compare 217,302 diabetes patients on GLP-1 medications with 217,302 matched patients on DPP-4 inhibitors. Patients on GLP-1s had a significantly lower risk of developing rheumatoid arthritis (HR = 0.87, p = 0.026), gout, and osteoarthritis within one year
Today they said it will be ready tomorrrow
